nalidixic acid has been researched along with Disease Models, Animal in 23 studies
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Porphyria cutanea tarda (PCT)-like photosensitivity eruptions have occurred in patients treated with nalidixic acid, furosemide (Lasix), or tetracycline." | 7.67 | Nalidixic acid-induced photosensitivity in mice: a model for pseudoporphyria. ( Keane, JT; Malkinson, FD; Pearson, RW, 1984) |
| "Porphyria cutanea tarda (PCT)-like photosensitivity eruptions have occurred in patients treated with nalidixic acid, furosemide (Lasix), or tetracycline." | 3.67 | Nalidixic acid-induced photosensitivity in mice: a model for pseudoporphyria. ( Keane, JT; Malkinson, FD; Pearson, RW, 1984) |
| "Twenty juvenile New Zealand white rabbits were dosed orally once daily with 1,000 mg of nalidixic acid/kg for 3, 7, and 14 consecutive days, then for 14 days followed by a 14-day recovery period." | 1.29 | Quinolone arthropathy in juvenile New Zealand white rabbits. ( Childress, CP; Henningsen, GM; Mastin, JP; Sharpnack, DD, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (69.57) | 18.7374 |
| 1990's | 2 (8.70) | 18.2507 |
| 2000's | 2 (8.70) | 29.6817 |
| 2010's | 1 (4.35) | 24.3611 |
| 2020's | 2 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Paulander, W | 1 |
| Pennhag, A | 1 |
| Andersson, DI | 1 |
| Maisnier-Patin, S | 1 |
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Kalsy, M | 1 |
| Tonk, M | 1 |
| Hardt, M | 1 |
| Dobrindt, U | 1 |
| Zdybicka-Barabas, A | 1 |
| Cytrynska, M | 1 |
| Vilcinskas, A | 1 |
| Mukherjee, K | 1 |
| Yang, SC | 1 |
| Huang, TH | 1 |
| Chiu, CH | 1 |
| Chou, WL | 1 |
| Alalaiwe, A | 1 |
| Yeh, YC | 1 |
| Su, KW | 1 |
| Fang, JY | 1 |
| Crump, JA | 1 |
| Barrett, TJ | 1 |
| Nelson, JT | 1 |
| Angulo, FJ | 1 |
| Keane, JT | 1 |
| Pearson, RW | 1 |
| Malkinson, FD | 1 |
| Sharpnack, DD | 1 |
| Mastin, JP | 1 |
| Childress, CP | 1 |
| Henningsen, GM | 1 |
| Videau, D | 1 |
| Jinnah, HA | 1 |
| Langlais, PJ | 1 |
| Friedmann, T | 1 |
| Brühl, P | 1 |
| Schmidt, HJ | 1 |
| Loew, H | 2 |
| Ritzerfeld, W | 4 |
| Rosini, S | 2 |
| Benetti, D | 2 |
| Henkel, W | 1 |
| Freiesleben, H | 1 |
| Wöhrmann, W | 1 |
| Commichau, R | 1 |
| Burrous, SE | 1 |
| Cawein, JB | 1 |
| Hatala, M | 2 |
| Prát, V | 6 |
| Konicková, L | 5 |
| Losse, H | 1 |
| English, AR | 1 |
| Rudzit, EA | 1 |
| Lisitsa, LI | 1 |
1 review available for nalidixic acid and Disease Models, Animal
| Article | Year |
|---|---|
[Experimental pyelonephritis, chemotherapeutic studies (review of the literature)].
Topics: Acute Disease; Ampicillin; Animals; Anti-Bacterial Agents; Chloramphenicol; Chronic Disease; Coryneb | 1971 |
22 other studies available for nalidixic acid and Disease Models, Animal
| Article | Year |
|---|---|
Caenorhabditis elegans as a model to determine fitness of antibiotic-resistant Salmonella enterica serovar typhimurium.
Topics: Animals; Caenorhabditis elegans; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Mice; | 2007 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
The insect antimicrobial peptide cecropin A disrupts uropathogenic Escherichia coli biofilms.
Topics: Animals; Antimicrobial Cationic Peptides; Biofilms; Cell Membrane Permeability; Disease Models, Anim | 2020 |
The atopic dermatitis-like lesion and the associated MRSA infection and barrier dysfunction can be alleviated by 2,4-dimethoxy-6-methylbenzene-1,3-diol from Antrodia camphorata.
Topics: Administration, Cutaneous; Animals; Anti-Bacterial Agents; Antrodia; Cell Line; Chemokines; Dermatit | 2018 |
Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae.
Topics: Anti-Infective Agents; Disease Models, Animal; Drug Resistance, Bacterial; Fluoroquinolones; Humans; | 2003 |
Nalidixic acid-induced photosensitivity in mice: a model for pseudoporphyria.
Topics: Animals; Biopsy; Disease Models, Animal; Female; Mice; Microscopy, Electron; Nalidixic Acid; Photose | 1984 |
Quinolone arthropathy in juvenile New Zealand white rabbits.
Topics: Animals; Cartilage, Articular; Cell Nucleus; Disease Models, Animal; Female; Femur; Histocytochemist | 1994 |
[Experimental pyelonephritis in rats: value in the comparison of antibiotics (author's transl)].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cefazolin; Cephaloridine; Cephalothin; Disease | 1976 |
Functional analysis of brain dopamine systems in a genetic mouse model of Lesch-Nyhan syndrome.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamines; Animals; Apomorphine; Brai | 1992 |
[The effect of nalidixic acid on the course of experimental pyelonephritis under the influence of resistance-affecting drugs].
Topics: Animals; Antibodies; Antibody Formation; Chemical Phenomena; Chemistry; Dehydroepiandrosterone; Dise | 1970 |
Piromidic acid and beta-hydroxypiromidic acid: therapeutic effectiveness on experimental E. coli pyelonephritis in the rat.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Escherichia coli Infections; Nalidixic Acid; | 1973 |
Urinary tract infection. Experimental induction in rats.
Topics: Animals; Anti-Infective Agents, Urinary; Disease Models, Animal; Kidney; Kidney Calculi; Male; Nalid | 1972 |
[Urinary tract infections. Experimental production in rats].
Topics: Animals; Disease Models, Animal; Diuresis; Kidney; Male; Nalidixic Acid; Proteus Infections; Proteus | 1972 |
[Serum resistance and "nephropathogenicity" of E. coli. IV. Changes of virulence in vitro and in vivo].
Topics: Ampicillin; Animals; Blood Bactericidal Activity; Chloramphenicol; Chronic Disease; Disease Models, | 1974 |
Rat pyelonephritis model suitable for primary or secondary screening.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Disease Models, Animal; Escherich | 1969 |
[Nalidixic acid sensitivity of an E. coli strain in experimental pyelonephritis].
Topics: Animals; Disease Models, Animal; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infe | 1969 |
[Sensitivity of an E. coli strain during therapy of experimental pyelonephritis using nalidixic acid].
Topics: Animals; Disease Models, Animal; Drug Resistance, Microbial; Escherichia coli; Female; Microbial Sen | 1970 |
[Experimental cystitis in rats and its chemotherapy].
Topics: Animals; Bacteriuria; Cystitis; Disease Models, Animal; Escherichia coli; Escherichia coli Infection | 1970 |
Activity of tetracyclines, nalidixic acids, and nitrofurantoin in two experimental models of Escherichia coli urinary tract disease in rats.
Topics: Animals; Cell Count; Disease Models, Animal; Escherichia coli Infections; Female; Kidney; Nalidixic | 1971 |
[Experimental chemotherapy].
Topics: Animals; Animals, Laboratory; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Disease Models, | 1972 |
[Importance of animal experiments for antibcterial therapy of infection of the urinary tract in man].
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Nalidixic Acid; Nitrofurantoin; Rats; Sulfam | 1971 |
[Comparison of the effects of gentamicin and other chemotherapeutic agents in experimental urinary tract infections].
Topics: Animals; Anti-Infective Agents; Cephalosporins; Colistin; Cystitis; Disease Models, Animal; Gentamic | 1970 |